Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients

Inclusion Criteria: 1. Patients who have been pre-diagnosed as cases of type-1 diabetes for a period not less than 1 year 2. Male or Female Patients \>= 18 and =\< 55 years of age. 3. Patients with BMI of 18.0 to 30.0 kg/m2 4. Patients who are cooperative, reliable, and agree to have regular injections of insulin and are willing to comply with protocol procedures. Exclusion Criteria: 1. A Patient who is pregnant or is currently breast-feeding. 2. A Patient with history of severe hypoglycemia within the past year 3. A Patient who is an employee of the Investigator, or a patient who has a direct involvement with the trial or other trials under the direction of the Investigator. 4. Patients who are Hepatitis B or C positive on testing or have positive medical history of HIV at screening. 5. Patients unlikely to comply with the study protocol e.g. unable to return periodically for subsequent visits.